ATE194338T1 - Diphenylthiazolderivate mit antiinflammatorischer aktivität - Google Patents

Diphenylthiazolderivate mit antiinflammatorischer aktivität

Info

Publication number
ATE194338T1
ATE194338T1 AT91905483T AT91905483T ATE194338T1 AT E194338 T1 ATE194338 T1 AT E194338T1 AT 91905483 T AT91905483 T AT 91905483T AT 91905483 T AT91905483 T AT 91905483T AT E194338 T1 ATE194338 T1 AT E194338T1
Authority
AT
Austria
Prior art keywords
alkanesulfonyl
halogenated
inflammatory activity
represents hydrogen
diphenylthiazole
Prior art date
Application number
AT91905483T
Other languages
English (en)
Inventor
Masaru Saita
Hisataka Inoue
Kouichi Ikesue
Noriyuki Fujimoto
Ikuo Shinohara
Yasuaki Taniguchi
Yoshiki Deguchi
Hidenao Minami
Kanji Noda
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE194338T1 publication Critical patent/ATE194338T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/50Nitrogen atoms bound to hetero atoms
    • C07D277/52Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT91905483T 1991-03-07 1991-03-07 Diphenylthiazolderivate mit antiinflammatorischer aktivität ATE194338T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1991/000310 WO1992015570A1 (fr) 1991-03-07 1991-03-07 Nouveau derive de diphenylthiazole

Publications (1)

Publication Number Publication Date
ATE194338T1 true ATE194338T1 (de) 2000-07-15

Family

ID=14014315

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91905483T ATE194338T1 (de) 1991-03-07 1991-03-07 Diphenylthiazolderivate mit antiinflammatorischer aktivität

Country Status (7)

Country Link
US (1) US5449783A (de)
EP (1) EP0592664B1 (de)
KR (1) KR960009425B1 (de)
AT (1) ATE194338T1 (de)
AU (1) AU654125B2 (de)
DE (1) DE69132293D1 (de)
WO (1) WO1992015570A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0790057B1 (de) * 1994-11-29 2002-06-05 Hisamitsu Pharmaceutical Co., Inc. Antibakterielle oder bakterizide mittel, die 2-aminothiazolderivate und deren salze enthalten
AU5886296A (en) 1995-06-02 1996-12-18 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclo oxygenase-2 and 5-lipoxygenase inhibitors
US6512121B2 (en) 1998-09-14 2003-01-28 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6515014B2 (en) 1995-06-02 2003-02-04 G. D. Searle & Co. Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6677364B2 (en) 1998-04-20 2004-01-13 G.D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2003015777A1 (en) * 2001-08-13 2003-02-27 Lion Bioscience Ag Nr1h4 nuclear receptor binding compounds
US7329401B2 (en) 2002-04-15 2008-02-12 The Regents Of The University Of California Cyclooxygenase-2 selective agents useful as imaging probes and related methods
EP1608365B1 (de) * 2003-03-31 2013-10-02 R-Tech Ueno, Ltd. Methoden zur behandlung von hyperpermeablen vaskularerkrankungen
EP4058439A1 (de) * 2019-11-12 2022-09-21 Genzyme Corporation 5-gliedrige heteroarylaminosulfonamide zur behandlung von durch mangelnde cftr aktivität vermittelten erkrankungen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458526A (en) * 1966-09-26 1969-07-29 Upjohn Co Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles
CH587836A5 (de) * 1974-01-31 1977-05-13 Serono Lab
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
DK150068C (da) * 1978-06-02 1987-06-29 Pfizer Analogifremgangsmaade til fremstilling af aminothiazoler
JPS57118574A (en) * 1981-01-13 1982-07-23 Mitsui Toatsu Chem Inc N-(4-phenylthiazol-2-yl)carbamate derivative, its preparation and medicinal composition containing the same
JPS5857366A (ja) * 1981-10-02 1983-04-05 Yamanouchi Pharmaceut Co Ltd 3,5−ジ−tert−ブチル−4−ヒドロキシフエニル置換複素環化合物
JPS58198474A (ja) * 1982-05-13 1983-11-18 Mitsui Toatsu Chem Inc アミノメチレンマロン酸エステル誘導体と製造法及び殺菌剤
DD225130A1 (de) * 1983-08-31 1985-07-24 Univ Berlin Humboldt Verfahren zur herstellung n-funktionalisierter 2-aminothiazole
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
JP3003148B2 (ja) * 1989-01-05 2000-01-24 藤沢薬品工業株式会社 チアゾール化合物、その製造法およびそれを含有する医薬組成物
EP0388909A3 (de) * 1989-03-22 1991-05-08 Fujisawa Pharmaceutical Co., Ltd. Thiazolderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
JPH078863B2 (ja) * 1989-09-21 1995-02-01 久光製薬株式会社 新規なジフェニルチアゾール誘導体
JPH04173782A (ja) * 1990-11-08 1992-06-22 Taisho Pharmaceut Co Ltd 2―スルホンアミド―4,5―ジフェニルチアゾール誘導体
GB2253297B (en) * 1991-02-27 1994-11-16 Mars Inc Coin validation

Also Published As

Publication number Publication date
EP0592664B1 (de) 2000-07-05
WO1992015570A1 (fr) 1992-09-17
KR960009425B1 (en) 1996-07-19
KR930703278A (ko) 1993-11-29
US5449783A (en) 1995-09-12
EP0592664A1 (de) 1994-04-20
DE69132293D1 (de) 2000-08-10
EP0592664A4 (en) 1994-06-22
AU654125B2 (en) 1994-10-27
AU7452791A (en) 1992-10-06

Similar Documents

Publication Publication Date Title
NO941101D0 (no) Quinazolin-derivater
DE69321525T2 (de) Morphinan-derivate und medizinische verwendung
FI953968A (fi) Antraniiliset happojohdannaiset
FI963238A (fi) Heteroaromaattisia oksatsoli yhdisteitä ja niiden käyttö
NO180166C (no) Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene
NO932607D0 (no) Piperidinderivater og anvendelse av disse
ATE68473T1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
ATE74132T1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
ATE45354T1 (de) Chinoloncarbonsaeurederivate.
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
DE69132293D1 (de) Diphenylthiazolderivate mit antiinflammatorischer aktivität
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
FR2449677B1 (fr) Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques
NO893039L (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.
ES2042727T3 (es) Acidos 1,3,4,9-tetrahidropirano(3,4-b)indol-1-acetico.
ATE134607T1 (de) Tetrahydronaphtalenderivate, ihre herstellung und ihre therapeutische verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties